StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Vaccinex's enterprise value was $1.59M on Oct 19, 2026, against $607.23K a year earlier. Over the last 5 years it ranged from -$314.27K to $52.67M, with a median of $5.19M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.59M-11.2%
2025Dec 31, 2025$1.80M–
2024Dec 31, 2024-$314.27K-109.8%
2023Dec 29, 2023$3.20M-84.3%
2022Dec 30, 2022$20.31M+4.6%
2021Dec 31, 2021$19.43M-64.2%
2020Dec 31, 2020$54.33M-23.5%
2019Dec 31, 2019$71.06M+85.3%
2018Dec 31, 2018$38.36M–

More Vaccinex figures

See a number that looks wrong?